Nothing Special   »   [go: up one dir, main page]

ES2014523A6 - Procedimiento de preparar derivados de aril-heteroarilcarbinoles. - Google Patents

Procedimiento de preparar derivados de aril-heteroarilcarbinoles.

Info

Publication number
ES2014523A6
ES2014523A6 ES8800984A ES8800984A ES2014523A6 ES 2014523 A6 ES2014523 A6 ES 2014523A6 ES 8800984 A ES8800984 A ES 8800984A ES 8800984 A ES8800984 A ES 8800984A ES 2014523 A6 ES2014523 A6 ES 2014523A6
Authority
ES
Spain
Prior art keywords
radical
heteroaryl
aryl
hydrogen atom
denotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8800984A
Other languages
English (en)
Inventor
Augusto Colombo
Juan Pares
Jordi Frigola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of ES2014523A6 publication Critical patent/ES2014523A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO DE PREPARAR DERIVADOS DE ARIL-HETEROARILCARBINOLES, DE LA INDICADA FORMULA GENERAL (I), EN EL CUAL PROCEDIMIENTO UN COMPUESTO DE FORMULA GENERAL (II) SE HACE REACCIONAR CON UN COMPUESTO DE FORMULA GENERAL (III) O (IV) O DE LA FORMULA GENERAL TENIENDO LOS SUSTITUYENTES LOS VALORES INDICADOS EN LA DESCRIPCION. LOS DERIVADOS OBTENIDOS SON UTILES COMO MEDICAMENTOS, ESPECIALMENTE PARA PREVENIR O TRATAR EL DOLOR DE INTENSIDAD MEDIA A ALTA.
ES8800984A 1987-04-10 1988-03-30 Procedimiento de preparar derivados de aril-heteroarilcarbinoles. Expired - Lifetime ES2014523A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705118A FR2613720B1 (fr) 1987-04-10 1987-04-10 Derives d'aryl-heteroaryl carbinols avec activite analgesique

Publications (1)

Publication Number Publication Date
ES2014523A6 true ES2014523A6 (es) 1990-07-16

Family

ID=9350010

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8800984A Expired - Lifetime ES2014523A6 (es) 1987-04-10 1988-03-30 Procedimiento de preparar derivados de aril-heteroarilcarbinoles.

Country Status (12)

Country Link
US (1) US5017596A (es)
EP (1) EP0289380B1 (es)
JP (1) JPH0651678B2 (es)
KR (1) KR930009442B1 (es)
AT (1) ATE116303T1 (es)
BR (1) BR1100931A (es)
DE (1) DE3852565T2 (es)
DK (1) DK172927B1 (es)
ES (1) ES2014523A6 (es)
FR (1) FR2613720B1 (es)
GR (1) GR3015616T3 (es)
PT (1) PT87183B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681322B1 (fr) * 1991-09-12 1993-12-17 Laboratorios Dr Esteve Sa Derives d'aryl-heteroaryl-{n-[2-(3,4-dimethoxyphenyl)-ethyl]-n-methyl-3-aminopropoxy}-methane leur preparation et leur application en tant que medicaments .
BR9507595A (pt) * 1994-05-02 1997-09-16 Zeneca Ltd Composto composição herbicida processo para controlar vegetação indesejável
ES2150353B1 (es) 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
DE10335566A1 (de) * 2003-07-31 2005-02-24 Grünenthal GmbH Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
ES2245226B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
CA2562231A1 (en) * 2004-04-05 2005-10-20 Laboratorios Del Dr. Esteve, S.A. Active substance combination of a carbinol compound and an opioid
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
EP1632227A1 (en) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
EP1671953A1 (en) 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining cizolirtine and its enantiomers
EP1671968A1 (en) 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1674465A1 (en) 2004-12-27 2006-06-28 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
WO2006087147A2 (en) * 2005-02-15 2006-08-24 Laboratorios Del Dr. Esteve, S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia
EP1690537A1 (en) * 2005-02-15 2006-08-16 Laboratorios Del Dr. Esteve, S.A. Derivatives of aryl(or heteroaryl) azolycarbinols for the treatment of fibromyalgia
EP1695704A1 (en) * 2005-02-28 2006-08-30 Laboratorios Del Dr. Esteve, S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia
ES2286920B1 (es) * 2005-02-15 2008-08-16 Laboratorios Del Dr. Esteve, S.A. Derivados de aril (o heteroaril)azolilcarbinoles para el tratamiento de la fibromialgia.
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7592362B2 (en) * 2006-01-19 2009-09-22 Pfizer Limited Substituted imidazoles
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
US20100291151A1 (en) * 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL39413A0 (en) * 1971-05-13 1972-07-26 Sparamedica Ag Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
JPS5118950B2 (es) * 1972-06-30 1976-06-14
US4853404A (en) * 1986-10-13 1989-08-01 Tanabe Seiyaku Co., Ltd. Phenoxyacetic acid derivatives composition and use

Also Published As

Publication number Publication date
JPS63267761A (ja) 1988-11-04
PT87183A (pt) 1988-05-01
DK170188A (da) 1988-10-11
DK170188D0 (da) 1988-03-28
FR2613720B1 (fr) 1990-01-19
JPH0651678B2 (ja) 1994-07-06
BR1100931A (pt) 1999-11-23
GR3015616T3 (en) 1995-06-30
PT87183B (pt) 1992-08-31
DE3852565D1 (de) 1995-02-09
FR2613720A1 (fr) 1988-10-14
US5017596A (en) 1991-05-21
KR930009442B1 (ko) 1993-10-04
DE3852565T2 (de) 1995-05-11
EP0289380A1 (fr) 1988-11-02
EP0289380B1 (fr) 1994-12-28
ATE116303T1 (de) 1995-01-15
KR880012558A (ko) 1988-11-28
DK172927B1 (da) 1999-10-04

Similar Documents

Publication Publication Date Title
ES2014523A6 (es) Procedimiento de preparar derivados de aril-heteroarilcarbinoles.
ES8100276A1 (es) Un procedimiento para la preparacion de nuevos derivados de-4-anilinoquinazolinas
MY104179A (en) Antidepressant n-substituted nicotinamide compounds.
TW347387B (en) Piperidine derivatives
AU531586B2 (en) Morpholine derivatives
NZ313185A (en) 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
EP0144986A3 (en) Indole-3-carboxamide derivatives
ES8406440A1 (es) Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina
MY109337A (en) Phenoxyl-and phenoxyalkyl-piperidines as antiviral agents
IE801615L (en) 4-phenoxypiperidine derivatives.
ES8401067A1 (es) Procedimiento analogo para preparar un derivado de tropil benzoato.
ES466366A1 (es) Un procedimiento para preparar derivados de metasulfonamido-benzamida.
MY129935A (en) Dihydropyridine derivatives useful in antitumor therapy
ES2131574T3 (es) Derivados de 1-(arilalquil-aminoalquil)imidazol, procedimientos de preparacion y uso como agentes terapeuticos.
ES8203855A1 (es) Un procedimiento para la preparacion de derivados de imida- lol.
DK59888D0 (da) Imidazolderivater
NZ335975A (en) Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases
IE802682L (en) Oxazoline derivatives
ES8403462A1 (es) Procedimiento para la obtencion de hidantoinas n-sulfeniladas.
MX9707672A (es) Compuesto azol con actividad antimicotica para el uso humano y veterinario.
MY102015A (en) Certain 2-(2-substituted benzoyl)-1, 3- cyclohexanadiones
MY107787A (en) Therapeutic agents

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20080331